skin-resident memory T cells
Vitiligo Treatment from the Iron Age to the Age of Biologics: New Hope for an Ancient Disease
Dr. Harris presented an overview of past and present treatments for vitiligo, including advances in vitiligo research and ongoing work to improve vitiligo treatment in the future. First, Dr. Harris described research that led to FDA approval of topical ruxolitinib for vitiligo. Dr. Harris sought to develop targeted immunotherapies that could treat vitiligo while avoiding…